Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
about
Adrenal steroid hormones and metaphyseal bone in children.The relevance of the procedures related to the physiotherapy in the interventions in patients with prostate cancer: short review with practice approach.Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an updateCurrent management of castrate-resistant prostate cancer.A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design.Guidelines for the management of castrate-resistant prostate cancer.Age-related decline in bone density among ethnically diverse older men.Risk stratification in the hormonal treatment of patients with prostate cancerAndrogen-deprivation therapy and bone loss in prostate cancer patients: a clinical review.Bone-modifying agents in the treatment of bone metastases in patients with advanced genitourinary malignancies: a focus on zoledronic acid.Prostate cancer in elderly Croatian men: 5-HT genetic polymorphisms and the influence of androgen deprivation therapy on osteopenia--a pilot studyBone densitometric assessment and management of fracture risk in Indian men of prostate cancer on androgen deprivation therapy: Does practice pattern match the guidelines?The effects of chlormadinone acetate on lower urinary tract symptoms and erectile functions of patients with benign prostatic hyperplasia: a prospective multicenter clinical study.Rates of and risk factors for trabecular and cortical BMD loss in middle-aged and elderly African-ancestry menNatural history and correlates of hip BMD loss with aging in men of African ancestry: the Tobago Bone Health Study.Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trialCorrelates of trabecular and cortical volumetric BMD in men of African ancestry.Emerging drugs for the management of cancer treatment induced bone loss.Emerging novel therapies in the treatment of castrate-resistant prostate cancer.Aging and osteoporosis in breast and prostate cancer.AST-induced bone loss in men with prostate cancer: exercise as a potential countermeasure.An exploratory study of the factors that influence physical activity for prostate cancer survivors.
P2860
Q31120005-AB638068-BCAD-4CDA-88E7-E50045A7C216Q33882588-D2E181D7-7373-441D-89A3-0579E0B1F709Q33900049-2A806767-1943-4568-8D2B-9FFE74796251Q34111641-7DF942C2-7C82-44FB-B022-D9EC80077D27Q34212887-57908251-34B0-4353-9F2C-74C1F57BA43CQ34384240-E18EA5B0-44BB-4CC0-BCB1-E122B6E7A890Q35020991-697FA5A1-9763-4116-9AB0-48CA60FAB495Q35076189-E55E1BA6-D70B-4F53-AE23-743C4FF01206Q35774987-164A02C2-7D39-474D-9B90-E110C57BD6B2Q35865726-2DC64EA3-4066-42AC-8949-A4BDD7C4EF2FQ36041671-431D638F-EDA3-44A7-9667-632A47B7EF81Q36628819-FA4DCEE0-5F90-4056-A20D-BD9AA1CCA29FQ36898650-298F4EAF-E80F-4950-8BCE-22A899469B6AQ36930725-428606CF-CE43-4208-AEF6-602596798732Q37230567-7AE0C468-E3AC-425F-8D61-428FAF38DE52Q37435405-4AB23BA7-F700-445B-8AF5-0C9694A78115Q37469359-328CFC29-A49A-457E-AC81-7A5380F4E7CEQ37727235-08737C9C-5026-450A-A840-B23E06C7CC09Q37862392-1696AFC8-8F08-477F-AEB9-5213736F723BQ37872146-4ECFD9E3-73BF-4C6F-A163-10CD43BF39F0Q38021668-2FD2B747-BCD5-4FC2-8AA7-C0295CDB38A0Q48196523-1C185356-3FEF-4B40-883A-EEB0E5062CE7
P2860
Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Androgen deprivation in men wi ...... n increased rate of bone loss.
@en
Androgen deprivation in men wi ...... n increased rate of bone loss.
@nl
type
label
Androgen deprivation in men wi ...... n increased rate of bone loss.
@en
Androgen deprivation in men wi ...... n increased rate of bone loss.
@nl
prefLabel
Androgen deprivation in men wi ...... n increased rate of bone loss.
@en
Androgen deprivation in men wi ...... n increased rate of bone loss.
@nl
P2093
P2860
P356
P1476
Androgen deprivation in men wi ...... n increased rate of bone loss.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.PCAN.4500599
P577
2002-01-01T00:00:00Z